Skip to main content
JANL
OTC Trade & Services

Janel Corp Q3 FY2026: Revenue Jumps 37% to $67.5M, Net Income More Than Doubles

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
7
Price
$50
Mkt Cap
$59.318M
52W Low
$21
52W High
$62
52W Position info
138% above low
Off High info
19% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

JANL has more than doubled off its 52-week low of $21.

Summary

Janel Corp reported a 37% revenue increase to $67.5M and net income more than doubled to $1.98M in Q3 FY2026, driven by Logistics growth and acquisitions. Cash surged to $33.7M, but $32M of that is customer tariff refunds.


Key Events · Earnings and Guidance · JANL

  • Revenue Surges 37% to $67.5M

    Consolidated revenue rose 37.4% YoY to $67.5M, with Logistics up 41.3% to $61.1M, driven by acquisitions ($8.4M contribution) and organic growth from higher freight rates and demand.

  • Net Income More Than Doubles

    Net income available to common stockholders reached $1.98M ($1.63 diluted EPS), up from $0.81M ($0.67 diluted EPS) in Q3 FY2025, reflecting operating leverage and a $849K gain on Rubicon consolidation.

  • Cash Balloons to $33.7M, but $32M is Customer Refunds

    Cash and equivalents jumped to $33.7M from $11.0M at fiscal year-end, primarily due to $32.0M in tariff refunds collected on behalf of customers — a liability, not operating cash.

  • Life Sciences Acquisitions and Rubicon Consolidation

    The company acquired a BioPorto antibody product line for $10M ($9M cash, $1M contingent) and a royalty agreement for $1.44M. It also consolidated Rubicon, recognizing an $849K bargain purchase gain.


Analysis · JANL · Trade & Services

A standout fiscal third quarter saw Janel Corporation's revenue leap 37% year-over-year to $67.5 million, fueled by acquisitions and strong organic momentum in its Logistics segment. Net income available to common stockholders more than doubled, reaching $1.98 million, or $1.63 per diluted share, compared with $0.81 million a year ago. The balance sheet strengthened markedly—cash and equivalents swelled to $33.7 million, largely reflecting $32 million in tariff refunds collected on behalf of customers. Two bolt-on acquisitions in the Life Sciences segment were completed, and the consolidation of Rubicon added a one-time gain. A new $59.1 million credit facility, closed in December 2025, refinanced prior debt and provides ample capacity for further acquisitions. While the results are positive, the stock trades at a high multiple, and the tariff refunds are a pass-through liability, not operating cash flow.

At the time of this filing, JANL was trading at $50.00 on OTC in the Trade & Services sector, with a market capitalization of approximately $59.3M. The 52-week trading range was $21.00 to $62.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JANL - Latest Insights

JANL
May 08, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
9
JANL
Feb 12, 2026, 8:03 PM EST
Filing Type: 10-Q
Importance Score:
9
JANL
Jan 02, 2026, 5:02 PM EST
Filing Type: 8-K
Importance Score:
8